05/21/2014 SomaGenics demonstrates that their short synthetic shRNAs function as a direct-acting anti-viral agent against Hepatitis C
01/06/2014 SomaGenics Reports on successful HCV virus inhibition with its therapeutic sshRNA
Exploiting miRNA’s Potential for Diagnostics and Drugs
SomaGenics Announces Issue of Key Patent for Its sshRNA Technology and Receipt of Two New Small Business Innovation NIH Grants
SomaGenics Reports Study on Mechanism of Action of Its Therapeutic Platform
SomaGenics’ sshRNA Technology Demonstrates Efficacy of RNAi Against Hepatitis C Virus
home | RNA Technologies | programs | partnering | company | contact | news
© 2014 SomaGenics. All rights reserved.